TY  - GEN
AU  - Braziel,Rita M
AU  - Launder,Teresa M
AU  - Druker,Brian J
AU  - Olson,Susan B
AU  - Magenis,R Ellen
AU  - Mauro,Michael J
AU  - Sawyers,Charles L
AU  - Paquette,Ronald L
AU  - O'Dwyer,Michael E
TI  - Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience
SN  - 0006-4971
PY  - 2002///0830
KW  - Adult
KW  - Aged
KW  - Benzamides
KW  - Blood Cells
KW  - cytology
KW  - Bone Marrow Cells
KW  - Cytogenetic Analysis
KW  - Drug Resistance
KW  - Female
KW  - Follow-Up Studies
KW  - Fusion Proteins, bcr-abl
KW  - analysis
KW  - Humans
KW  - Imatinib Mesylate
KW  - Interferon-alpha
KW  - administration & dosage
KW  - Karyotyping
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Philadelphia Chromosome
KW  - Piperazines
KW  - Pyrimidines
KW  - Remission Induction
KW  - methods
KW  - Retrospective Studies
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1182/blood.v100.2.435
ER  -